Team advantages
100% of the enterprise's research and development team has a bachelor's degree or above, with a master's or doctoral ratio of 40%. The company's main research personnel have rich experience in new drug development, technology transfer, and clinical production reporting. The team members complement each other's professional advantages, effectively ensuring project development and management, and can comprehensively carry out project lifecycle development until the product industrialization is fully put into operation.
Dr. Michael Yin
Chief Scientist
Vice President of Guangdong Nanshan Pharmaceutical Innovation Research Institute
Professor PI of State Key Laboratory of Respiratory Diseases
Chief Scientist of Guangzhou Michelangela Pharmaceutical Research Institute Co., Ltd
General Manager
Jiang Wenmin ,Clinical Medicine
Chengdu University of Traditional Chinese Medicine, majoring in Clinical Medicine, has nearly 30 work experience and has worked in the entire chain of drug sales, research and development, and production. Organized the development of over 20 drugs, put nearly 10 drugs into production, and obtained multiple patents. One of the founders of Michelangela, achieved full operation of the company in 2019.
Research and Development Director
Li Zhen, Master's degree
With over 10 years of experience in chemical drug development.
Led the entire research and development process of over 10 chemical drug projects from initiation to launch. Having rich experience in drug development and industrialization.
Expert Advisor
Professor Cai Chun
Professor and doctoral supervisor at Guangdong Medical University, expert in drug analysis and targeted drug development, with rich experience in new drug research and development. Received multiple national funding projects and scientific and technological achievements awards.
Expert Advisor
Professor Lin Guangyi
Professor and doctoral supervisor at the University of Technology Sydney, Australia. Specializing in the study of lung injury mechanisms and the pharmacology of non-steroidal anti-inflammatory drugs (NSAIDs), we have also made many pioneering work in the development of special drug formulations and in vitro diagnostic techniques.
Expert Advisor
Professor Sudhir Vaid
Indian biotechnologist who has worked for several leading international biotechnology companies. With over 40 years of rich experience in the fields of enterprise, research and development, and consulting, Mr. Vaid has collaborated with leading global companies in the field of biotechnology, including vitamins, statins, hormones, and antibiotics, and has gained good reputation.